Home I About Us I Contact RxAssist

Patient Assistance Program Center

Patient Assistance Program Eligibility Criteria and Medicare Part D

Will your Medicare patients be eligible for Patient Assistance Programs?
Updates are made as they are received. Last updated October 14, 2009.

No Medicare Patients may apply for PAPs

Acorda

Advanced Vision

Alaven

American Regent

Arch

Auxilium

Axcan

Bausch & Lombe

Baxter

Biovitrum

Boehringer Ingleheim

Cell Theraputics

Cephalon

CSL Behring

Cubist
Dermik

Ecr

EKR

Elan (see Part D)

Eisai (Part D see below)

EMD (Part D below)

EUSA

Ferndale

Grifols

GTX

IVAX

Lundeck (formerly Ovation)

Mallinckrodt (Part D below )

MEDA (see below)

MedImmune

Medtronic

Millenium

Novan

Purdue

Ocusoft

Reckitt-Benckiser
Reliant

Romark

Salix

Savient

Sciele Pharma

Strativa

Teva/Gate

The Medicine Company

Triax

Ucycl;yd Pharma

Valeant

Validus

Watson

Wellspring

Medicare Patients without a Part D plan may apply for PAPs

Alpharma

Amgen (Part D see below)

Amylin

Astellas Pharma (Part D see below)

AstraZeneca (Part D see below)

Bayer

Berlex

Biovail

Daiichi Sankyo

Duramed

Eli Lilly (Part D see below)

Endo

Enzon

ESP

Galderma

Genentech

Genzyme (Part D see below)

Graceway

Intermune

King

MedPointe

MGI
NitroMed

Novo-Nordisk

Ortho-Biotech (Part D see below)

Reckett Benckiser

Roche (Part D see below)

Salix

Serono

Shire (Part D see below)

Sigma

Solvay

Three Rivers (case by case)

Upsher-Smith

Valeant (Part D see below)
Vistakon

All Medicare Patients may apply for PAPs

Abbott *

Accredo

Actelion (Part D only)

Alcon (Part D enrollees must submit a hardship letter)

Alexion (case by case review)

Allergan*

Ascend

AstraZeneca-Part D enrollees use AZ & Me Savings Programs for people with Medicare Part D

Aton

Beach

Biogen (case by case)

BioMarin(case by case)

Bristol Myer Squibb*

Celgene

Cetylite

Columbia

Digestive Care

Eyetech

Forest (denial letter needed)

Fresenius

Gilead*

GlaxoSmithKline-Part D enrollees use GSK Access program

Glenwood- (case by case)

Johnson & Johnson*

Kos

Mallinckrodt case by case

Merck*

Merck/Schering Plough *

NABI (Cannot be LIS eligible)

Novartis

Pfizer* (Some medications may not be available to Part D enrollees)

Primus

Procter & Gamble (Cannot be LIS eligible)

Sanofi-Aventis (Appeal process for Medicare enrolled, financially-needed patients who have a life threatening condition confirmed by physician)

Schering-Plough

Sepracor

Stiefel

Takeda*

UCB
Wyeth (Part D enrollees must submit a hardship letter or LIS denial letter)

Medicare Part D patients may apply for selected medications

Amgen- Sensipar and Enbrel only

Astellas Pharma - Prograf and Amevive

Blairex- (case by case)

Eisai - Aricept only

Elan- case by case

Eli Lilly - Zyprexa, Forteo and Humatrope only through LillyMedicareAnswers

EMD- novantrone infusion and Rebif subcutaneous

Genzyme - Renagel only through Renagel Part D PAP

Jazz-xyrem case by case, Luvox Cr point of sale discount card

Ligand--only if drugs not in patient’s Part D plan

MEDA-patients in Donut Hole may be considered

Ortho-Biotech - Only if drugs not in patient's Part D plan

Questor (Part D only)

Roche - Only if drugs not in patient's Part D plan

Shire - some Medicare Part D patients may be eligible

Valeant - Only if drugs not in patient's Part D plan; Part D enrollees ineligible for Infergen PAP

LIS = Low-Income Subsidy within Part D
*Will consider allowing some Part D enrollees to apply for PAPs; contact the company for more information.

If you should have additional information about a pharmaceutical company's response to Medicare Part D and its PAP, please contact us.

About Us I Contact I SiteMap I Privacy I Terms of Use